Transcatheter technologies could be the future – but a distant one.
Abbott’s latest aortic valve launch is unlikely to gain it a meaningful slice of the market; meanwhile, Edwards’ attention has switched to tricuspid.
Medtronic’s quarterly results yesterday might presage a recovery, and some groups are in dire need of one.
Beset with problems from the off, the Lotus Edge aortic valve has finally been discontinued.
Welcome to the calm before the Covid-19 storm.
The Covid-19 pandemic has scythed vast sums from joint makers’ Q2 sales. But Medtronic’s summer earnings were better than those for its spring quarter.
Medtronic has had a poor quarter owing to the pandemic – but Zimmer’s has been even worse.